Laurence I. Barsh, DMD, Founder of Snoring Isn't Sexy, to speak at Somnomed's First Annual... (eting the dental sleep medicine practice...)

Laurence I. Barsh, DMD, Founder of Snoring Isn't Sexy, to speak at Somnomed's First Annual Symposium

Date:8/1/2009

eting the dental sleep medicine practice - Collaborative Social Marketing™ - a technique that takes advantage of all that Web 2.0 has to offer.

About Snoring Isn't Sexy, LLC
Snoring Isn't Sexy, LLC was founded in 2008 by Laurence I. Barsh, DMD, a dentist who has been involved with sleep medicine since 1992 and who now devotes full time to educating the public about dentistry's role and responsibility in the recognition and management of snoring and sleep apnea. Dr. Barsh and the dentists associated with Snoring Isn't Sexy, LLC feel strongly that management of sleep-breathing disorders is a shared responsibility of both the medical and dental professions.

Snoring Isn't Sexy, LLC consists of independently owned and operated affiliated offices. Visit http://www.SnoringIsntSexy.com for a directory of all participating dentists.

Contact:
Laurence I. Barsh, DMD
888.203.0488
315 East 70th St., #7H
New York, NY 10021

###

Read the full story at http://www.prweb.com/releases/Stop_Snoring/Sleep_Apnea/prweb2707654.htm.

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2
Related medicine news :

1. Laurence Debroux Appointed Chief Strategic Officer (CSO)
2. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
3. Center for Health Transformation Founder Newt Gingrich Calls on Congress to Pass a Clean SCHIP Six-Month Extension
4. Forbes Honors Susan G. Komen for the Cure Founder as Trailblazer
5. Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years
6. Susan G. Komen for the Cure Founder Sworn in as Chief of Protocol
7. FalconStor Software Inc. Founders Make Multi-Million Dollar Donation to North Shore-LIJ Health System for Asian Community Health Center in Flushing
8. GeoVax Co-Founder Dr. Harriet Robinson Named 2007 AAAS Fellow
9. Former NFL Star Tiki Barber and CURE Founder Susan Axelrod Speak Out About Epilepsy on TODAY Show
10. Lenny Dykstra, Founder & President of The Players Club, to Keynote the 2008 Financial Communications Forum
11. Intel Co-Founder Andrew S. Grove Dedicates Portion of His Estate, Up to $40 Million, to Michael J. Fox Foundation

Post Your Comments:

Related Image:

Laurence I. Barsh, DMD, Founder of Snoring Isn't Sexy, to speak at Somnomed's First Annual Symposium

(Date:11/21/2009)... Nov. 21 A regional ini...rciasis (river blindness) in the Americas has subs... recent years, as evidenced by a 31% decrease in t...istration in six endemic countries. Results were ...merican Society of Tropical Medicine and Hygiene (...

(Date:11/21/2009)... NH based medical credentialing software company ...form a partnerhsip with Amerinet, Inc., the leadin...will help to transform quality care within the hea... November 21, 2009 -- ISG Group, LLC, doing busine...ment with Amerinet Inc., a leading national health...

(Date:11/21/2009)... Eric J. Hall, president and chief executive offi... issued the following statement regarding the incl... the new annual wellness for Medicare beneficiarie...are Act" that was introduced last night: , ...er 21, 2009 -- Eric J. Hall, president and chief e...

(Date:11/20/2009)...urologist Closer to Understanding Brain Wiring and...Newswire/ -- Dr. Jeremy Schmahmann, Professor of N... at the Massachusetts General Hospital in Boston, ...,s research on the new field of study called "Conn.... ,, Dr. Schmahmann is an award-winning leader ...

(Date:11/20/2009)...ON, Nov. 20 The United ...nate to make essential changes its health reform b...ion funding and conscience protection on abortion,...include strong provisions for adequate affordabili...e bill an "enormous disappointment" that creates n...

Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2 Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3 Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4 Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2 Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2 Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3 Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2 Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2

[0] River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries [0] IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care [0] Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform [0] MINDlink Foundation Launches to Connect the Cerebellum to Cures [0] U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability

...UVER, Feb. 24 /PRNewswire-FirstCall/ - CRH Medical...nership Program, the CRH O,Regan Hemorrhoid bandin...the gastroenterologist practice groups trained by ...ency of its training methodology. The sharing of k...

...EATTLE, Feb. 24, 2009 As Zimbabwe continues to co...d sanitation infrastructure, a new,World Vision pr... PG ) Children,s,Safe Drinking Water Program is ...://www.newscom.com/cgi-bin/prnh/20090115/CLTH035LO...

...NGTON, Feb. 24 As genetic tests become more affor...nalized medical information that can help them man...ion and treatment. But not all genetic tests are c...ican Clinical Laboratory Association and its educa...

...inds better concentration, lowered stress after,TM...News) -- Meditation might help protect college stu...learn, suggests a study that examined the effects ...nderwent physiological and psychological tests and...

...ce uses search engine optimization and individuali...h Yellow Page ads , , ST. LOUIS, Feb. 24 Creativ...he launch of My Hometown Vet , a cost-effective w... Hometown Vet uses a combination of search engine ...

...LISO VIEJO, Calif., Feb. 24 Valeant,Pharmaceutica...urth quarter and,full year financial results for 2...inning to take hold in the fourth,quarter, we cont...r future revenue and cash flow potential by acquir...

CRH provides Partnership Program update Procter & Gamble and World Vision Equip and Empower Zimbabweans in Fight Against Cholera Six Questions Consumers Should Ask About Genetic Tests Meditation May Boost College Students' Learning Creative Marketing Solutions Launches My Hometown Vet, Giving Veterinary Practices Better Visibility Online Valeant Pharmaceuticals Reports Fourth Quarter and Full Year Financial Results

(Date:11/20/2009)...-FirstCall/ -- Escalon Medical Corp. (Nasdaq Marke...t quarter ended September 30, 2009. ,, For th...creased approximately $234,000, or 2.7%, to $8,435... 30, 2009 as compared to the same period last fisc...evenue of $8,434,000 compared with $8,669,000 in f...

(Date:11/20/2009)...wire-FirstCall/ -- Landauer, Inc. ( LDR) , wi... quarter and full year of 2009 pre-market on Tuesd...a conference call for investors on Tuesday, Decemb...ay access the live call by dialing 877-941-9205 (w...35 (international callers), or by visiting the "In...

(Date:11/20/2009)...ire/ -- Reportlinker.com announces that a new mark...,, Pipettes & Pipettors - A Global Market ...0164373/Pipettes--Pipettors---A-Global-Market-Pers...pr&utm_campaign=prnewswire ,, Pipettes an... research laboratory. Large-scale applications in ...

Breaking Medicine Technology:Escalon(R) Reports First Quarter Fiscal 2010 Results 2 Escalon(R) Reports First Quarter Fiscal 2010 Results 3 Escalon(R) Reports First Quarter Fiscal 2010 Results 4 Escalon(R) Reports First Quarter Fiscal 2010 Results 5 Escalon(R) Reports First Quarter Fiscal 2010 Results 6 Escalon(R) Reports First Quarter Fiscal 2010 Results 7 Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12 Cleveland Lawyers Recognized by Peers on The Best Lawyers in America List 57298 1 Cleveland Lawyers Recognized by Peers on The Best Lawyers in America List 57298 2 Cleveland Lawyers Recognized by Peers on The Best Lawyers in America List 57298 3 Implementing QA Automation Tools in an FDA Controlled Software Environment a Free Webinar 14071 1 Implementing QA Automation Tools in an FDA Controlled Software Environment a Free Webinar 14071 2 Top 15 Pharmaceutical Company Awards Cardiac Safety Study to iCardiac 14069 1 Top 15 Pharmaceutical Company Awards Cardiac Safety Study to iCardiac 14069 2

[0] Escalon(R) Reports First Quarter Fiscal 2010 Results [0] Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results [0] Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective

...itional protection against,infection with virus ty...candidate vaccine, PHILADELPHIA, June 27, 2007 /PR...lysis of a Phase III study show that,CERVARIX(R), ...ine,provides up to 100 percent protection against...common types of human papillomavirus,types 16 and...

... with VELCADE, cyclophosphamide,and prednisone al...ewswire-FirstCall/ -- Millennium,Pharmaceuticals, ...,from clinical trials of VELCADE based therapies t...onse(1) (CR) rates in previously,treated multiple ...ed at the prestigious 11th International Myeloma W...

Other Medicine Technology:Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 2 Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 3 Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 4 Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 5 Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 6 Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 7 Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 2 Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 3 Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 4 Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 5 Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma 6

Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma

...nded memory capabilities for overnight sleep scree...ygen saturation and pulse rate data, and can opera...s:, ,1. The Model 130 can retain up to 30 min...he device ideally suited for treadmill or other lo...

BCI 3303 Hand-Held Pulse Oximeter w/Rechargeable Battery

... fourth in the Clarity Series is a cost-effective,... with 3 or 5 lead ECG, pace detect/reject, digital...logy, and respiration. A high-resolution electrol...urable traces. An optional recorder (Smiths Medic...

...Management Program is a Windows based, easy-to-use...Held Pulse Oximeter. Using the Smiths Medical PM,...wnloads information collected during sleep screeni...ies, and assists in the Clinician's interpretation...

Medicine Products:

Model 130 Pulse Oximeter BCI 3303 Hand-Held Pulse Oximeter w/Rechargeable Battery Autocorr Plus Pulse Oximeter/ECG/Respiration Monitor Oximetry Data Management Program

Laurence I. Barsh, DMD, Founder of Snoring Isn't Sexy, to speak at Somnomed's First Annual...(eting the dental sleep medicine practice...),Health